Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2a randomized double-blind placebo-controlled study of JNJ-40346527 in active rheumatoid arthritis
KCT0000564Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of edicotinib in rheumatoid arthritis (RA), sponsored by Janssen Pharmaceutical. Started Jul 2012; status: completed.
02
Drugs
edicotinib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on KCT0000564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000564.